Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CF33-CD19t |
Synonyms | |
Therapy Description |
CF33-CD19t is an oncolytic vaccinia virus that delivers a truncated CD19 antigen to tumor cells, potentially resulting in antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CF33-CD19t | onCARlytics | CF33-CD19t is an oncolytic vaccinia virus that delivers a truncated CD19 antigen to tumor cells, potentially resulting in antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06063317 | Phase I | CF33-CD19t Blinatumomab + CF33-CD19t | A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (OASIS) | Recruiting | USA | 0 |